PT  - JOURNAL ARTICLE
AU  - Misra-Press, Anita
ED  - Thatcher, Nicholas
TI  - Age-Stratified Subgroup Analysis of SQUIRE in Patients With Stage IV Squamous NSCLC
DP  - 2015 Jun 19
TA  - MD Conference Express
PG  - 14--14
VI  - 15
IP  - 8
4099  - http://mdc.sagepub.com/content/15/8/14.1.short
4100  - http://mdc.sagepub.com/content/15/8/14.1.full
AB  - An age-stratified subgroup analysis of the SQUIRE trial demonstrated that patients aged < 70 years exhibited significant survival benefits when necitumumab was added to gemcitabine/cisplatin chemotherapy as first-line treatment for stage IV squamous non–small cell lung cancer. This survival advantage was not observed in the elderly ≥ 70-year subgroup.